Ai For Health[4]

Onsite Event Participants

Carlotta Altringer

VitrofluidiX (Germany)

Drug discovery

Celia Antonio Schell

MultiOmic Health Limited (United Kingdom)

Drug discovery

prevention

Jonathan Apasu

Adon Health (Germany)

Virtual care

prevention

Alex Apelbaum

AA Global Consulting (Switzerland)

Matteo Berlucchi

CEO
Healthily (formerly Your.MD) (United Kingdom)

Bartosz Borucki

Smarter Diagnostics (Poland)

prevention

Paulus Carpelan

Adamant Health oy (Finland)

Virtual care

prevention

Pedro Castel-Branco

Armilar Venture Partners (Portugal)

Virtual care

Drug discovery

prevention

Mathieu Chaffard

Roche Diagnostics International (Switzerland)

Virtual care

Drug discovery

prevention

Fabrizio Conicella

head Open Innovation & Competence
Chiesi Farmaceutici (Italy)

Virtual care

Antoine D'Hollander

Investment Manager
Capricorn Partners (Belgium)

Virtual care

prevention

Sune Darkner

DARERL ApS (Denmark)

Virtual care

prevention

Soumya Dash

Sleepiz AG (Switzerland)

Virtual care

Drug discovery

prevention

Coenraad Davidsdochter

Senior Consultant
Qserve Group (Netherlands)

Virtual care

prevention

Blagovesta Dlagatseva

Investors Club Manager & Business Development
Tech Tour (Bulgaria)

Jana Drechsler

Project Management Healthcare
EWG - Essener Wirtschaftsförderung (Germany)

Virtual care

Omar El Nahhas

StratifAI (Germany)

Virtual care

Drug discovery

prevention

Jan Engels

Investment Manager
High-Tech Gruenderfonds (HTGF) (Germany)

Virtual care

Drug discovery

prevention

Roberta Ferrari

Managing Director
EQT Life Sciences (Netherlands)

Eva Garcia Ramos

e-HEALTH TECHNICAL SOLUTIONS SL (Spain)

Virtual care

Annalisa Gardella

Team Leader
Tech Tour Europe (Belgium)

Jan-Eric Gawande

aalto health GmbH (Germany)

Virtual care

prevention

Bart Geerts

Healthplus.ai (Netherlands)

Virtual care

prevention

Nedelcho Georgiev

Columbo (Bulgaria)

Virtual care

prevention

Maria Georgieva

Project Manager Healthtech
Tech Tour (Bulgaria)

Ioannis Gkouzionis

Aisthesis Medical (United Kingdom)

Virtual care

prevention

Nicolas Guggenheim

Independent Board Member and Strategic Investor in Healthcare
- (Switzerland)

Virtual care

Vishal Gulati

Managing Partner
Recode Health Ventures (United States)

Noushin Hadadi

Novigenix SA (Switzerland)

Drug discovery

prevention

Tyler Hayes

Principal
Thuja Capital (Netherlands)

Drug discovery

prevention

Jannis Heuner

Managing Director
ruhrHUB (Germany)

Drug discovery

Mario Huyghe

Senior Venture Development Manager
imec (Belgium)

Virtual care

Drug discovery

Juho Immonen

Data Scientist
Bayer (Germany)

Drug discovery

prevention

Torsten Heerdegen Jepsen

CEO & CO-FOUNDER
Aiomic (Denmark)

prevention

Georgi Kadrev

Kelvin Health (Bulgaria)

prevention

Alper Karagoz

Partner
Diffusion Capital Partners (DCP) (Turkiye)

prevention

Jörg Kemna

CEO
Business Metropole Ruhr GmbH (Germany)

Dan Kirkland

Board Member
Sheffield Chamber of Commerce (United Kingdom)

Virtual care

Bernard Kirsch

Angels Santé (France, Metropolitan)

prevention

Philipp Kopp

Investment Manager
bmp Ventures (Germany)

Drug discovery

Lauri Kuronen

CEO, Denmark unit
LKP-Invest (Finland)

Virtual care

Philippa Köhnk

BRYCK (Germany)

prevention

Nicolas Lagreze

Head of Venture Building
Fusion Partners (Switzerland)

Virtual care

prevention

Maarten Larmuseau

Nuclivision (Belgium)

Virtual care

Drug discovery

Robert Lauritzen

Cerebriu (Denmark)

Daniel Leite

AI4MedImaging - Medical Solutions S.A. (Portugal)

prevention

Steven Leuridan

Partner
Qbic (Belgium)

Virtual care

Drug discovery

prevention

Alex Loleyt

Traverse Health (Netherlands)

Drug discovery

Kirill Lopatin

xAID (Spain)

Virtual care

Drug discovery

Friedrich Lämmel

Thryve (Germany)

Virtual care

prevention

Sebastian Merkel

Junior Professorship for Health and E-Health
Digi Health Start (Germany)

Karsten Miermans

hema.to (Germany)

Virtual care

Drug discovery

Marco Mohwinckel

Tech Tour Advisor
Magnolia Health Advisors (United Kingdom)

Virtual care

prevention

Czuee Morey

Xena Dx (Germany)

Virtual care

Antonio Murta

Managing Director
Pathena (Portugal)

prevention

Erki Mölder

Managing Partner
Verge Capital Management (Singapore)

Virtual care

prevention

Samuel Müller

ATLAS medical technology GmbH (Germany)

Virtual care

Kazuhiro Nakamura

Senior Manager, Healthcare
Teijin Holdings Europe B.V. (Netherlands)

Peter Nestorov

Scailyte AG (Switzerland)

Drug discovery

prevention

Nicolas Olberg

IT Investor & Managing Director
Twip Impact Ventures (Germany)

Virtual care

Manuel Opitz

deepeye Medical GmbH (Germany)

Virtual care

Andreas Ostendorf

Head of Chair
Ruhr Universitaet Bochum LAT (Germany)

Xavier Pardo

Managing Director
Xerpa (Switzerland)

prevention

Juan Carlos Ondategui Parra

Co-Founder
e-HEALTH TECHNICAL SOLUTIONS SL (Spain)

Virtual care

prevention

Giuseppina Pavesi

Expert
down2business (Italy)

Tuomo Pentikäinen

CEO
Veil.ai (Finland)

Virtual care

Johannes Peuling

Head of Agency HealthCampus Bochum
Bochum Wirtschaftsentwicklung (Germany)

Virtual care

Kustaa Piha

CEO and Investor in Healthcare and Medtech
Athensmed Oy (Finland)

Virtual care

prevention

Steffen Preuß

icho systems (Germany)

prevention

Stefan Raue

Nooku (United Kingdom)

prevention

Thomas Roth

Inzipio GmbH (Germany)

Virtual care

prevention

Dietmar Schlößer

Director Digitalization & Innovation
TÜV NORD GROUP (Germany)

Virtual care

prevention

Mehrdad Seirafi

Alpha Brain Technologies (Netherlands)

Virtual care

Maria Severina

CEO, Angel Investor
Almaral (Finland)

Virtual care

prevention

Lauri Sippola

Gosta Labs (Finland)

Virtual care

Marc Sommer

spexa GmbH (Germany)

prevention

Remi Spagnol

Investments Healthcare
Supernova Invest (France)

Virtual care

Drug discovery

prevention

Natalie Sporrer

Elixion Medical (Germany)

Virtual care

Christian Stephan

Managing Director
KAIROS - an IQVIA business (Germany)

prevention

William Stevens

Group Managing Director
Tech Tour Europe (Belgium)

Klaus Stoeckemann

Managing Partner & Co-Founder
Peppermint Venture Partners (Germany)

prevention

Philip Taillieu

Cascador health (Belgium)

Drug discovery

Jukka Tapaninen

Aiforia Technologies Plc (Finland)

Drug discovery

prevention

Robert Thong

Chief Executive Officer
MultiOmic Health Limited (United Kingdom)

Drug discovery

Benno Tieke

Philips Ventures (Netherlands)

Nikolay Todorov

xAID (Spain)

Virtual care

prevention

Corina Turner

Smart In Media AG (Germany)

Virtual care

Drug discovery

prevention

Anna Maria Ullmann

Yeda (former YoniCore) by CoreCreation UG (Germany)

Virtual care

prevention

Ralph BMH van Aken

CEO & Owner
Wolf Nose (Netherlands)

Virtual care

prevention

Tom Van De putte

Co-founder, CEO
Bingli (Belgium)

Virtual care

prevention

Kristof Van Emelen

Obulytix (Belgium)

Drug discovery

Vanessa Vaughn

Project Manager
Ruhr Universitaet Bochum LAT (Germany)

Virtual care

Corinna Weber

SNAP DISCOVERY AG (Germany)

Virtual care

prevention

Martin Weihrauch

Smart In Media AG (Germany)

James Wilson

Vice President
Silverpeak (United Kingdom)

Drug discovery

Luuk Winkens

Autoscriber (Netherlands)

Virtual care

Thomas Wollinger

CEO
Bochum Wirtschaftsentwicklung (Germany)